EP1636257A2 - PEPTIDES ENHANCING CEH ACTIVITY OR ACAT INHIBITORY ACTIVITY, PHARMACEUTICAL COMPOSITIONS COMRISING THESE PEPTIDES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS